Pre-Visit Guidance For Older Adults With Type 2 Diabetes Leads To Informed, Collaborative Decisions About Treatment

Older adults with type 2 diabetes who received an information handout regarding medication deprescribing and the balance of risks and benefits were more likely to agree to a medication review, according to a recent clinical trial. Medication deprescribing is defined as reducing dose or frequency or discontinuing drugs, with the goal of minimizing drug-related adverse effects and associated clinical complications, the study stated. The study randomly assigned participants with type 2 diabetes who were age 75 years and older, had hemoglobin A1c of 8.0% or lower, and were treated with insulin and/or sulfonylureas to an intervention group . . .